Saba Capital Management, L.P.Saba Capital Management, L.P.

Institutional investor · Portfolio as of Q4 2025

SEC EDGAR SourceSEC Filings

Top Holdings350 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
ECATECAT
Fund

BLACKROCK ESG CAP ALLC TERM

26.3M$405.1M12.0%$11.63+16.65%
5 qtrssince 2024-Q4
Decreased
0
ASAASA
Fund

ASA GOLD AND PRECIOUS MTLS L

5.4M$321.7M9.6%$32.19+87.13%
5 qtrssince 2024-Q4
Increased
69
XGDVXXGDVX
Fund

GABELLI DIVID & INCOME TR

5.8M$159.7M4.7%$27.68+12.05%
5 qtrssince 2024-Q4
Decreased
0
PDXPDX
Fund

PIMCO DYNAMIC INCOME STRATEG

6.8M$127.6M3.8%$19.87-10.21%
5 qtrssince 2024-Q4
Decreased
0
GAMGAM
Fund

GENERAL AMERN INVS CO INC

2.1M$122.5M3.6%$47.64+23.43%
5 qtrssince 2024-Q4
Increased
56
NFJNFJ
Fund

VIRTUS DIVIDEND INTEREST & P

8.6M$111.4M3.3%$11.69+10.69%
5 qtrssince 2024-Q4
Increased
63
NBXGNBXG
Fund

NEUBERGER NEXT GENERATION

7.7M$111.1M3.3%$10.98+24.16%
5 qtrssince 2024-Q4
Decreased
0
BSTZBSTZ
Fund

BLACKROCK SCIENCE & TECHNOLO

4.6M$103M3.1%$18.10+19.40%
5 qtrssince 2024-Q4
Increased
67
MEGIMEGI
Fund

NYLI CBRE GBL INFR MEGTRNDS

5.6M$77M2.3%$10.39+24.91%
5 qtrssince 2024-Q4
Decreased
0
PEOPEO
Fund

ADAM NAT RES FD INC

2.7M$58.7M1.7%$18.63+9.94%
5 qtrssince 2024-Q4
Increased
46
TSLATSLA
PUT

TESLA INC

113,100$50.9M1.5%
Increased
BPREBPRE
Fund

BLUEROCK PVT REAL ESTATE FD

3.1M$46.1M1.4%$14.200.00%
1 qtr
New
67
CRWDCRWD
PUT

CROWDSTRIKE HOLDINGS INC - A

88,200$41.3M1.2%
Increased
LEOLEO
Fund

BNY MELLON STRATEGIC MUNS IN

6.1M$38.6M1.1%$5.64+8.97%
5 qtrssince 2024-Q4
Increased
49
QCOMQCOM
PUT

QUALCOMM INC

224,600$38.4M1.1%
Increased
NVDANVDA
PUT

NVIDIA CORP

205,900$38.4M1.1%
Decreased
NQPNQPDelisted
Fund

NUVEEN PA INVT QUALITY MUN F

3M$35.7M1.1%$10.08
5 qtrssince 2024-Q4
Decreased
0
HQLHQL
Fund

ABRDN LIFE SCIENCES INVESTOR

2.1M$35.5M1.1%$11.55+45.71%
5 qtrssince 2024-Q4
Decreased
0
MXFMXF
Fund

MEXICO FD INC

1.7M$34.1M1.0%$17.52+9.45%
3 qtrssince 2025-Q2
Increased
58
AMDAMD
PUT

ADVANCED MICRO DEVICES

157,900$33.8M1.0%
Decreased
$3.4B
AUM
350
Positions
Q4 2025
Filing
Rating · 2.0
Quarterly Portfolio Change
-13%Q1'25$3.7B+15%Q2'25$4.3B-14%Q3'25$3.7B-8%Q4'25$3.4B
Activity profile
$ moved · Q4'25
New22%Increased20%Decreased27%Exited31%
Composition
Equity vs derivatives
Equity89%Puts11%Calls0%
Holding period
Avg 2.2 quarters
<1Q26%1-4Q33%1-2Y41%2Y+0%

Saba Capital Management, L.P. manages $3.4B across 350 positions as of Q4 2025. Top holdings: ECAT (12.0%), ASA (9.6%), XGDVX (4.7%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 2/5.0.

Q4 2025 Summary

Active quarter - 85 new positions, 61 exits, 52 increased. Top move: ASA (INCREASED, conviction 69). Portfolio: $3.4B across 350 positions.

Top holdings by portfolio weight

Total AUM$3B
ECAT12.04%
ASA9.56%
XGDVX4.75%
PDX3.79%
GAM3.64%
NFJ3.31%
NBXG3.30%
BSTZ3.06%
MEGI2.29%
PEO1.74%
Other1.37%

Portfolio allocation by GICS sector

Sectors11
Unknown82.27%
Financial Services6.59%
Technology3.14%
Communication Services2.57%
Consumer Cyclical2.37%
Industrials1.52%
Real Estate0.63%
Healthcare0.44%
Basic Materials0.18%
Consumer Defensive0.15%
Other0.14%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Below Average(2.0 / 5.0)
Track Record47
Conviction33
Concentration60
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
6Q
GFGFNEW GERMANY FD INC
Q1 2025 Q2 2026+2M shares+$29M
5Q
RMTRMTROYCE MICRO-CAP TR INC COM
Q2 2025 Q2 2026+3.3M shares+$48.6M
4Q
HFROHFROHIGHLAND OPPS & INCOME FD
Q3 2025 Q2 2026+3.7M shares+$30.8M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used